Get started
Author

Gloria Kayani

Observed names: G Kayani, G. Kayani, Kayani G, Kayani, G, Kayani, Gloria
ORCID: 0000-0001-9677-2993
Observed ORCID: 0000-0001-9677-2993
OpenAlex ID: A5065723634
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
2013 · Ajay K. Kakkar, Iris Mueller, et al. · PLoS ONE · 444
PDF
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF
2016 · Jean-Pierre Bassand, Gabriele Accetta, et al. · European Heart Journal · 288
PDF
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
2016 · A John Camm, Gabriele Accetta, et al. · Heart · 240
PDF
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry
2016 · Sylvia Haas, Hugo ten Cate, et al. · PLoS ONE · 157
PDF
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation
2017 · Keith A A Fox, Joseph E Lucas, et al. · BMJ Open · 152
PDF
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants
2020 · Alan John Camm, Frank Cools, et al. · Journal of the American College of Cardiology · 146
PDF
Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants
2023 · Rahul Aggarwal, Christian T. Ruff, et al. · Circulation · 114
PDF
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE
2020 · Jeffrey I. Weitz, Sylvia Haas, et al. · Journal of Thrombosis and Thrombolysis · 114
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry
2018 · Walter Ageno, Sylvia Haas, et al. · Thrombosis and Haemostasis · 111
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation
2018 · Jean-Pierre Bassand, Gabriele Accetta, et al. · PLoS ONE · 105
PDF
Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation
2019 · Jean-Pierre Bassand, Saverio Virdone, et al. · Circulation · 85
PDF
Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?
2015 · Gregory Y.H. Lip, Sophie K. Rushton-Smith, et al. · Circulation Cardiovascular Quality and Outcomes · 85
PDF
Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry
2016 · Seil Oh, Shinya Goto, et al. · International Journal of Cardiology · 81
Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry
2021 · Jean-Pierre Bassand, Saverio Virdone, et al. · Blood Advances · 69
PDF
Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry
2019 · Sebastian M. Schellong, Samuel Z. Goldhaber, et al. · Thrombosis and Haemostasis · 68
PDF
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial
2022 · Frank Cools, Saverio Virdone, et al. · The Lancet Haematology · 61
PDF
Clinical Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation Presentations in GARFIELD-AF: Implications for AF Screening
2021 · Harry Gibbs, Ben Freedman, et al. · The American Journal of Medicine · 61
PDF
Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry
2019 · Walter Ageno, Sylvia Haas, et al. · Thrombosis and Haemostasis · 59
PDF
Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease
2020 · Shinya Goto, Sylvia Haas, et al. · JAMA Network Open · 57
PDF
Global Anticoagulant Registry in the Field – Venous Thromboembolism (GARFIELD-VTE)
2016 · Sylvia Haas, Walter Ageno, et al. · Thrombosis and Haemostasis · 56
Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry
2019 · Shinya Goto, Pantep Angchaisuksiri, et al. · Journal of the American Heart Association · 54
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry
2021 · Frank Cools, Dana Johnson, et al. · Journal of Thrombosis and Haemostasis · 49
PDF
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation
2021 · Keith A A Fox, Saverio Virdone, et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 46
PDF
GARFIELD-AF: A Worldwide Prospective Registry of Patients With Atrial Fibrillation at Risk of Stroke
2020 · Jean-Pierre Bassand, Patricia N Apenteng, et al. · Future Cardiology · 43
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry
2017 · Freek W A Verheugt, Haiyan Gao, et al. · European Heart Journal · 43
Works count: 123
Citation count: 3,574
H-index: 32
I10-index: 55
Year
Topic
Type